Clinical Trials Logo

Venous Stasis Ulcer clinical trials

View clinical trials related to Venous Stasis Ulcer.

Filter by:

NCT ID: NCT00852995 Completed - Venous Leg Ulcer Clinical Trials

Dose Finding Study of HP802-247 in Venous Leg Ulcers

Start date: February 2009
Phase: Phase 2
Study type: Interventional

This is a 16-week study for subjects with a venous leg ulcer between the knee and ankle. This research is being done to determine the effectiveness of two dosing frequencies and two different concentrations of HP802-247, together with standard care, compared to placebo, plus standard care.

NCT ID: NCT00832091 Completed - Clinical trials for Venous Stasis Ulcers

Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers

SSVS
Start date: July 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and effectiveness of Thymosin Beta 4 administered topically in patients with Venous Stasis ulcers

NCT ID: NCT00823446 Completed - Clinical trials for Venous Stasis Ulcers

Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers

Start date: March 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to perform a preliminary evaluation of the safety of Revera Wound Care when topically applied to venous leg ulcers for 8 weeks of treatment.

NCT ID: NCT00815217 Not yet recruiting - Diabetic Wounds Clinical Trials

The Role of Lipoaspirate Injection in the Treatment of Diabetic Lower Extremity Wounds and Venous Stasis Ulcers

Start date: February 2009
Phase: N/A
Study type: Interventional

A prospective, single blinded randomized clinical study will be performed to determine if the injection of lipoaspirate into diabetic or venous stasis wounds promotes wound healing or wound closure at a faster rate than conventional treatment.

NCT ID: NCT00720239 Completed - Clinical trials for Venous Insufficiency

Taliderm Dressing for Venous Ulcers

Start date: February 2008
Phase: Phase 0
Study type: Interventional

The study will test a new wound healing dressing called Taliderm® on leg ulcers caused by chronic venous insufficiency (CVI). Some people with CVI have poor vein circulation that causes ulcers to develop on the lower legs. This new dressing is hoped to help the ulcers heal more quickly. The study hypothesis is to determine whether the TalidermR Wound Dressing, a poly-N-acetyl glucosamine (pGlcNAc) derived membrane material expedites wound healing in humans with venous stasis ulcers.

NCT ID: NCT00570141 Completed - Clinical trials for Venous Stasis Ulcers (VSU)

OASIS Wound Matrix (Oasis) Mechanism of Action

Start date: October 2007
Phase: Phase 4
Study type: Interventional

OASIS Wound Matrix (Oasis) will be applied to wounds, with sequential biopsy of healing wounds to explore the mechanism of action.

NCT ID: NCT00534937 Terminated - Venous Stasis Ulcer Clinical Trials

Flexitouch Compression System for Venous Stasis Ulcer

Start date: September 2007
Phase: Phase 4
Study type: Interventional

The researchers hypothesize that utilization of the Flexitouch system will improve the healing rates of (venous stasis ulcers) VSU compared to traditional compression wrapping therapy alone. Primary Objective: The primary study objective is to determine whether the complete healing rate of venous stasis ulcers at 12 weeks is improved by the addition of Flexitouch® System compression therapy to a standard regimen of compression wrapping. Secondary Objectives: - To determine whether the addition of Flexitouch System compression therapy to a standard regimen of compression wrapping increases the percentage reduction in wound surface area. - To determine whether the addition of Flexitouch compression therapy to a standard regimen of compression wrapping increases the percentage reduction in volume of the affected limb. - To determine whether the addition of Flexitouch compression therapy to a standard regimen of compression wrapping decreases the time to healing of the venous stasis ulcer.

NCT ID: NCT00425178 Completed - Diabetes Clinical Trials

FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers

Start date: September 2, 2005
Phase: Phase 1
Study type: Interventional

FGF-1 is being used for the treatment of patients with diabetic or venous stasis ulcers. Procedure includes topical administration of FGF-1 or placebo and evaluation of safety, pharmacokinetics, and wound improvement.

NCT ID: NCT00270946 Completed - Venous Leg Ulcer Clinical Trials

Evaluation of Bilayered Cellular Matrix (OrCel) for the Treatment of Venous Ulcers

Start date: April 2002
Phase: N/A
Study type: Interventional

This study was designed to evaluate the clinical benefits and safety of OrCel in the treatment of venous ulcers. OrCel and standard care were compared to standard care alone. Standard care consisted of currently accepted compression therapy. Patients were treated for 12 weeks. Patients with healed ulcers were followed for an additional 12 weeks to assess durability of the healed wound.